Denison Mines Corp Ordinary Shares (Canada) vs Eli Lilly And Co — how do they compare? Denison Mines Corp Ordinary Shares (Canada) trades at $2.38 (market cap $2.33B), while Eli Lilly And Co trades at $1,166.02 (market cap $1.06T). The key difference: Eli Lilly And Co is far larger — about 454.9× Denison Mines Corp Ordinary Shares (Canada)'s market cap, and Eli Lilly And Co pays a 0.58% dividend while Denison Mines Corp Ordinary Shares (Canada) pays none. Which is the better fit depends on your goals — on Pluang, investors hold Denison Mines Corp Ordinary Shares (Canada) for 0 Days and Eli Lilly And Co for 93 Days on average.
| DNN | LLY | |
|---|---|---|
Market Cap | $2.33B | $1.06T |
Volume | 20,155,849 | 2,297,239 |
Sector | Energy | Health |
52-Week High | $4.37 | $1.28K |
52-Week Low | $2.27 | $799.57 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $2.17B | $1.11T |
Dividend Yield | — | 0.58% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,169.93, up 1.07% on the day, with a bullish technical signal and strong fundamental momentum. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $8.38 exceeding the $6.40 estimate. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Positive news flow highlights promising pipeline updates in weight-loss and diabetes drugs, reinforcing growth prospects.
Outlook remains favorable given dominant market position and innovation pipeline, though high valuation multiples pose a risk. Analyst consensus is strongly bullish with a $1,340 price target. Key risks include competitive pressures and execution challenges in scaling production to meet demand for blockbuster therapies.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Denison Mines is a uranium mining, development, and exploration company focused on Canada's Athabasca Basin. Its portfolio includes the Wheeler River project and interests in other uranium projects and processing facilities.
Read more on DNN →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →